Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.
about
Indacaterol (arcapta neohaler) for chronic obstructive pulmonary diseaseSafety of chronic obstructive pulmonary disease medications: a primary care perspective.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.
P2860
Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@en
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@nl
type
label
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@en
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@nl
prefLabel
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@en
Indacaterol: pharmacologic pro ...... treatment of adults with COPD.
@nl
P2860
P356
P1476
Indacaterol: pharmacologic pro ...... treatment of adults with COPD
@en
P2093
Christopher K M Hui
P2860
P356
10.1586/ERS.10.91
P577
2011-02-01T00:00:00Z